The frequency of Ki67+ proliferating cells was similar in the residual tumor regions of the IRE + αPD1, IRE + dMSN‐SB, and the triple therapy groups, and these were significantly lower than those in the sham control or IRE groups (Figure 6D,G). Here, MKI67 is linked to neoplasm.